| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/05/2001 | WO2001023560A2 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 04/05/2001 | WO2001023559A1 Osteoclast differentiation factor regulatory region |
| 04/05/2001 | WO2001023558A2 Human secretory molecules |
| 04/05/2001 | WO2001023557A1 Novel polypeptides and genes encoding the same |
| 04/05/2001 | WO2001023556A1 Novel hemopoietin receptor protein, nr12 |
| 04/05/2001 | WO2001023555A1 Method of prolonging normal cell life span |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023553A2 Metastasis-associated antigen c4.4a |
| 04/05/2001 | WO2001023552A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | WO2001023551A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023549A1 Rat osteoclast differentiation factor |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023544A1 Nucleic acid fragment, recombinant vector containing the same and method of promoting the expression of structural gene by using the same |
| 04/05/2001 | WO2001023543A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023539A2 Genes encoding sterol delta-15 reductase in plants |
| 04/05/2001 | WO2001023538A2 Molecules for disease detection and treatment |
| 04/05/2001 | WO2001023533A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 04/05/2001 | WO2001023530A1 Genes expressed in germinating seeds and their uses |
| 04/05/2001 | WO2001023523A2 Secreted proteins and uses thereof |
| 04/05/2001 | WO2001023522A2 Compositions and methods for p53-mediated repression of gene expression |
| 04/05/2001 | WO2001023521A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023429A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 04/05/2001 | WO2001023428A2 Interleukin-2 receptor associated polypeptides |
| 04/05/2001 | WO2001023427A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023426A2 Hypoxia-related human genes, proteins, and uses thereof |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023424A1 A phosphatidylethanolamine binding protein (pebp-2) and uses thereof |
| 04/05/2001 | WO2001023423A1 A novel gene encodes the human huntingtin interacting polypeptide which comprises the ww domain and its producing method and application |
| 04/05/2001 | WO2001023422A1 Vaccine |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2001023420A2 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 04/05/2001 | WO2001023419A2 Differentially expressed genes |
| 04/05/2001 | WO2001023418A1 YphC |
| 04/05/2001 | WO2001023417A2 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses |
| 04/05/2001 | WO2001023416A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | WO2001023415A2 Method for extracting bacterio-rhodopsin |
| 04/05/2001 | WO2001023414A2 Immunologically significant herpes simplex virus antigens |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023404A1 Drug target isogenes: polymorphisms in the interleukin-4 gene |
| 04/05/2001 | WO2001023403A1 ypga CLADE GENES |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023002A1 Method for inhibition of pathogenic microorganisms |
| 04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | WO2001022984A1 Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
| 04/05/2001 | WO2001022920A2 Colon and colon cancer associated polynucleotides and polypeptides |
| 04/05/2001 | WO2001022916A2 Novel hev antigenic peptide and methods |
| 04/05/2001 | WO2001022816A1 MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 04/05/2001 | WO2001022811A1 Transgenic animal expressing a multiple mutated form of presenilin 1 |
| 04/05/2001 | WO2001022810A2 Transgenic animals expressing von willebrand factor (vwf) and vwf-related polypeptides |
| 04/05/2001 | WO2001022804A1 Fertility restorer gene for 'polima' cytoplasmic male sterility |
| 04/05/2001 | WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 04/05/2001 | WO2000078787A8 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE) |
| 04/05/2001 | WO2000076455A3 Chicken growth hormone releasing hormone receptor |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000073334A3 Human sorting nexins |
| 04/05/2001 | WO2000072023A3 Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 04/05/2001 | WO2000071573A3 Immunogenic peptides derived from mage and the use thereof |
| 04/05/2001 | WO2000070059A3 Signal transduction genes and methods of use |
| 04/05/2001 | WO2000068420A3 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 04/05/2001 | WO2000066782A3 Diagnostic assay for diabetes mellitus based on mutational burden |
| 04/05/2001 | WO2000066752A3 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide |
| 04/05/2001 | WO2000066143A8 Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
| 04/05/2001 | WO2000065027A3 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 04/05/2001 | WO2000061738A3 Differential regulation of gene expression in oncogenic transformation |
| 04/05/2001 | WO2000061617A3 Transiently immortalized cells for use in gene therapy |
| 04/05/2001 | WO2000060087A3 Cyclin dependent kinase inhibitor genes from plants |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000055343A3 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 04/05/2001 | WO2000052164A3 Potassium channel molecules and uses therefor |
| 04/05/2001 | WO2000031254A9 Apoptosis-inducing factor |
| 04/05/2001 | WO2000029578A9 Cloning and characterization of two m-rna transcription factors |
| 04/05/2001 | WO2000020450A9 Calcium channel alpha-2/delta gene |
| 04/05/2001 | WO2000002522A9 Anthrax vaccine |
| 04/05/2001 | WO1999060126A9 Protein z-dependent protease inhibitor |
| 04/05/2001 | DE19948679A1 Nucleic acid sequences from human endothelial cells, useful for gene therapy of angiogenesis and for identifying antiangiogenic agents |
| 04/05/2001 | DE19947456A1 New synthetic derivatives of the C-peptide of proinsulin, useful in the preparation of human insulin or insulin analogs in high yield |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | CA2811455A1 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorganisms from clinical specimens for diagnosis |
| 04/05/2001 | CA2397786A1 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 04/05/2001 | CA2389203A1 Human secretory molecules |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386077A1 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | CA2386032A1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2386028A1 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2385887A1 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385880A1 Novel human organic anion transporter-like proteins and polynucleotides encoding the same |
| 04/05/2001 | CA2385791A1 Molecules for disease detection and treatment |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | CA2385633A1 Paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | CA2385609A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | CA2385416A1 Fertility restorer gene for "polima" cytoplasmic male sterility |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |